AMVUTTRA®
AMVUTTRA® is a medicine authorised by Swissmedic under authorisation number 69074. The authorisation holder is Alnylam Switzerland GmbH. The medicinal product code is Transplant: gene therapy product and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 June 2023 and the authorisation is limited until 22 June 2028. ATC code N07XX18 places the medicine in the group Other nervous system drugs.
| Authorisation number | 69074 |
|---|---|
| Name | AMVUTTRA® |
| Full name | AMVUTTRA®, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Alnylam Switzerland GmbH |
| Medicinal product code | Transplant: gene therapy product |
| Dispensing category | B · Prescription only |
| ATC code | N07XX18 |
| First authorisation | 23 June 2023 |
| Authorisation validity | 22 June 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | AMVUTTRA®, Injektionslösung in einer Fertigspritze | B | 23 June 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | N07XX18 | 01.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is AMVUTTRA® authorised in Switzerland?
Yes. AMVUTTRA® is authorised by Swissmedic under authorisation number 69074, data as of 01 September 2026. The authorisation is limited until 22 June 2028.
Which dispensing category does AMVUTTRA® have?
AMVUTTRA® is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of AMVUTTRA®?
The authorisation holder is Alnylam Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.